[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person] [HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong KongR.] [HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]